Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro
Plants · 30.01.2023 · 12 (3) · 611
DOI: 10.3390/plants12030611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plants, online erschienen am 30.01.2023. Verfasst von Martin Kello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic, Slovak Research and Development Agency, Operational Programme Integrated Infrastructure, funded by the ERDF.
Abstract (Originalsprache)
Lichen metabolites represent a wide range of substances with a variety of biological effects. The present study was designed to analyze the potential antiproliferative, antimicrobial and antioxidative effects of several extracts from lichens (Pseudevernia furfuracea, Lobaria pulmonaria, Cetraria islandica, Evernia prunastri, Stereocaulon tomentosum, Xanthoria elegans and Umbilicaria hirsuta) and their secondary metabolites (atranorin, physodic acid, evernic acid and gyrophoric acid). The crude extract, as well as the isolated metabolites, showed potent antiproliferative, cytotoxic activity on a broad range of cancer cell lines in 2D (monolayer) and 3D (spheroid) models. Furthermore, antioxidant (2,2-diphenyl-1-picryl-hydrazylhydrate (DPPH) and in vitro antimicrobial activities were assessed. Data showed that the lichen extracts, as well as the compounds present, possessed biological potential in the studied assays. It was also observed that the extracts were more efficient and their major compounds showed strong effects as antiproliferative, antioxidant and antibacterial agents. Moreover, we demonstrated the 2D and 3D models’ importance to drug discovery for further in vivo studies. Despite the fact that lichen compounds have been neglected by the scientific community for long periods, nowadays they are objects of investigation based on their promising effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia.
- Department of Botany, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, 041 67 Košice, Slovakia.
- Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy, 041 81 Košice, Slovakia.
ORCID-Profile: Martin Kello, Michal Goga, Richard Frenak, Ludmila Tkacikova, Jan Mojzis
Förderung
- Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic
- Slovak Research and Development Agency
- Operational Programme Integrated Infrastructure, funded by the ERDF
Zitieren
APA
Kello, M., Goga, M., Kotorova, K., Sebova, D., Frenak, R., Tkacikova, L., & Mojzis, J. (2023). Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro. Plants, 12(3), 611. https://doi.org/10.3390/plants12030611
Vancouver
Kello M, Goga M, Kotorova K, Sebova D, Frenak R, Tkacikova L, et al. Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro. Plants. 2023;12(3):611. doi:10.3390/plants12030611
BibTeX
@article{Kello2023,
author = {Kello, Martin and Goga, Michal and Kotorova, Klaudia and Sebova, Dominika and Frenak, Richard and Tkacikova, Ludmila and Mojzis, Jan},
title = {Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro},
journal = {Plants},
year = {2023},
volume = {12},
number = {3},
pages = {611},
doi = {10.3390/plants12030611}
}
EUVIMED